Kazia Therapeutics Limited ADR (NASDAQ:KZIA)’s traded shares stood at 0.46 million during the last session, with the company’s beta value hitting 2.22. At the close of trading, the stock’s price was $1.26, to imply a decrease of -15.99% or -$0.24 in intraday trading. The KZIA share’s 52-week high remains $15.80, putting it -1153.97% down since that peak but still an impressive -3.97% since price per share fell to its 52-week low of $1.31. The company has a valuation of $4.20M, with an average of 10.82 million shares in intraday trading volume over the past 10 days and average of 1.85 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Kazia Therapeutics Limited ADR (KZIA), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give KZIA a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.
Kazia Therapeutics Limited ADR (NASDAQ:KZIA) trade information
After registering a -15.99% downside in the last session, Kazia Therapeutics Limited ADR (KZIA) has traded red over the past five days. The 5-day price performance for the stock is -20.25%, and -27.99% over 30 days. With these gigs, the year-to-date price performance is -28.81%. Short interest in Kazia Therapeutics Limited ADR (NASDAQ:KZIA) saw shorts transact 18773.0 shares and set a 0.11 days time to cover.
KZIA Dividends
Kazia Therapeutics Limited ADR has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Kazia Therapeutics Limited ADR (NASDAQ:KZIA)’s Major holders
In total, 7.06% institutions holds shares in the company, led by MORGAN STANLEY. As of 2024-06-30, the company held over 0.2 million shares (or 0.8386% of shares), all amounting to roughly $45967.0.
The next major institution holding the largest number of shares is BNP PARIBAS ARBITRAGE, SNC with 63568.0 shares, or about 0.2651% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $14532.0.
Going by data provided on Nov 30, 2024 , Fidelity NASDAQ Composite Index Fund holds roughly 1.48 shares. This is just over 0.03% of the total shares, with a market valuation of $1862.0
